Literature DB >> 28931691

Vertical Transmission of Hepatitis C Virus: Variable Transmission Bottleneck and Evidence of Midgestation In Utero Infection.

Sébastien Fauteux-Daniel1,2, Ariane Larouche1,2, Virginie Calderon1,2,3, Jonathan Boulais4, Chanel Béland1,2, Doris G Ransy1,2, Marc Boucher5,6, Valérie Lamarre5,7, Normand Lapointe5,7, Isabelle Boucoiran5,6, Armelle Le Campion1,2, Hugo Soudeyns8,2,7.   

Abstract

Hepatitis C virus (HCV) can be transmitted from mother to child during pregnancy and childbirth. However, the timing and precise biological mechanisms that are involved in this process are incompletely understood, as are the determinants that influence transmission of particular HCV variants. Here we report results of a longitudinal assessment of HCV quasispecies diversity and composition in 5 cases of vertical HCV transmission, including 3 women coinfected with human immunodeficiency virus type 1 (HIV-1). The population structure of HCV variant spectra based on E2 envelope gene sequences (nucleotide positions 1491 to 1787), including hypervariable regions 1 and 2, was characterized using next-generation sequencing and median-joining network analysis. Compatible with a loose transmission bottleneck, larger numbers of shared HCV variants were observed in the presence of maternal coinfection. Coalescent Bayesian Markov chain Monte Carlo simulations revealed median times of transmission between 24.9 weeks and 36.1 weeks of gestation, with some confidence intervals ranging into the 1st trimester, considerably earlier than previously thought. Using recombinant autologous HCV pseudoparticles, differences were uncovered in HCV-specific antibody responses between coinfected mothers and mothers infected with HCV alone, in whom generalized absence of neutralization was observed. Finally, shifts in HCV quasispecies composition were seen in children around 1 year of age, compatible with the disappearance of passively transferred maternal immunoglobulins and/or the development of HCV-specific humoral immunity. Taken together, these results provide insights into the timing, dynamics, and biologic mechanisms involved in vertical HCV transmission and inform preventative strategies.IMPORTANCE Although it is well established that hepatitis C virus (HCV) can be transmitted from mother to child, the manner and the moment at which transmission operates have been the subject of conjecture. By carrying out a detailed examination of viral sequences, we showed that transmission could take place comparatively early in pregnancy. In addition, we showed that when the mother also carried human immunodeficiency virus type 1 (HIV-1), many more HCV variants were shared between her and her child, suggesting that the mechanism and/or the route of transmission of HCV differed in the presence of coinfection with HIV-1. These results could explain why cesarean section is ineffective in preventing vertical HCV transmission and guide the development of interventions to avert pediatric HCV infection.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  bioinformatics; bottleneck; hepatitis C virus (HCV); high-throughput sequencing; human immunodeficiency virus type 1 (HIV-1); pregnancy; vertical transmission

Mesh:

Substances:

Year:  2017        PMID: 28931691      PMCID: PMC5686730          DOI: 10.1128/JVI.01372-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Actively acquired tolerance of foreign cells.

Authors:  R E BILLINGHAM; L BRENT; P B MEDAWAR
Journal:  Nature       Date:  1953-10-03       Impact factor: 49.962

2.  Chorioamnionitis is associated with placental transmission of human immunodeficiency virus-1 subtype E in the early gestational period.

Authors:  Lertlakana Bhoopat; Surapan Khunamornpong; Pannee Sirivatanapa; Tat Rithaporn; Piyaporn Lerdsrimongkol; Paul S Thorner; Tanin Bhoopat
Journal:  Mod Pathol       Date:  2005-10       Impact factor: 7.842

3.  Evolution of hepatitis C virus quasispecies in children with chronic hepatitis C.

Authors:  M Gerotto; M Resti; F Dal Pero; I Migliorato; A Alberti; F Bortolotti
Journal:  Infection       Date:  2006-04       Impact factor: 3.553

4.  The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

Authors:  P Farci; A Shimoda; A Coiana; G Diaz; G Peddis; J C Melpolder; A Strazzera; D Y Chien; S J Munoz; A Balestrieri; R H Purcell; H J Alter
Journal:  Science       Date:  2000-04-14       Impact factor: 47.728

Review 5.  Hepatitis C virus in pregnancy.

Authors:  Mona R Prasad; Jonathan R Honegger
Journal:  Am J Perinatol       Date:  2013-02-06       Impact factor: 1.862

6.  Differing patterns of liver disease progression and hepatitis C virus (HCV) quasispecies evolution in children vertically coinfected with HCV and human immunodeficiency virus type 1.

Authors:  Sophie Canobio; Cynthia M Guilbert; Myriam Troesch; Johanne Samson; Mireille Lemay; Veronique Anne Pelletier; Anne-Claude Bernard-Bonnin; Rafal Kozielski; Normand Lapointe; Steven R Martin; Hugo Soudeyns
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

7.  HCV/HIV co-infection, HCV viral load and mode of delivery: risk factors for mother-to-child transmission of hepatitis C virus?

Authors:  Eugènia Mariné-Barjoan; Alain Berrébi; Valérie Giordanengo; Sébastien Fournier Favre; Hervé Haas; Michel Moreigne; Jacques Izopet; Joelle Tricoire; Albert Tran; Christian Pradier; André Bongain
Journal:  AIDS       Date:  2007-08-20       Impact factor: 4.177

8.  Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences.

Authors:  Jeremy Goecks; Anton Nekrutenko; James Taylor
Journal:  Genome Biol       Date:  2010-08-25       Impact factor: 13.583

9.  DNACLUST: accurate and efficient clustering of phylogenetic marker genes.

Authors:  Mohammadreza Ghodsi; Bo Liu; Mihai Pop
Journal:  BMC Bioinformatics       Date:  2011-06-30       Impact factor: 3.169

10.  Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host.

Authors:  Richard J P Brown; Natalia Hudson; Garrick Wilson; Shafiq Ur Rehman; Sara Jabbari; Ke Hu; Alexander W Tarr; Persephone Borrow; Michael Joyce; Jamie Lewis; Lin Fu Zhu; Mansun Law; Norman Kneteman; D Lorne Tyrrell; Jane A McKeating; Jonathan K Ball
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

View more
  5 in total

1.  Hepatitis C virus infection in mothers and children.

Authors:  Emma Greenaway; Mia J Biondi; Jordan J Feld; Simon C Ling
Journal:  Can Liver J       Date:  2019-12-10

2.  Hepatitis B and C Viruses' Infection and Associated Factors among Pregnant Women Attending Antenatal Care in Hospitals in the Amhara National Regional State, Ethiopia.

Authors:  Mulat Dagnew; Yihenew Million; Mucheye Gizachew; Setegn Eshetie; Gashaw Yitayew; Lakachew Asrade; Mulat Adefris; Feleke Moges; Moges Tiruneh
Journal:  Int J Microbiol       Date:  2020-10-09

Review 3.  Genetic bottlenecks in intraspecies virus transmission.

Authors:  John T McCrone; Adam S Lauring
Journal:  Curr Opin Virol       Date:  2017-11-03       Impact factor: 7.090

4.  Identification of Conserved Amino Acid Substitutions During Serial Infection of Pregnant Cattle and Sheep With Bovine Viral Diarrhea Virus.

Authors:  Thibaud Kuca; Thomas Passler; Benjamin W Newcomer; John D Neill; Patricia K Galik; Kay P Riddell; Yijing Zhang; Paul H Walz
Journal:  Front Microbiol       Date:  2018-06-06       Impact factor: 5.640

5.  Apolipoprotein E polymorphism influences orthotopic liver transplantation outcomes in patients with hepatitis C virus-induced liver cirrhosis.

Authors:  José Carlos Rodrigues Nascimento; Lianna C Pereira; Juliana Magalhães C Rêgo; Ronaldo P Dias; Paulo Goberlânio B Silva; Silvio Alencar C Sobrinho; Gustavo R Coelho; Ivelise Regina C Brasil; Edmilson F Oliveira-Filho; James S Owen; Pierluigi Toniutto; Reinaldo B Oriá
Journal:  World J Gastroenterol       Date:  2021-03-21       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.